HHS: Plan B access will stay limited

May 15, 2017

Bloomberg Businessweek: "The decision follows by two years a federal court ruling that age restrictions on the pill were arbitrary, based more on political pressure than safety. On Dec. 13, the FDA is scheduled to explain today's decision to the court" (Frier and Peterson, 12/7).

NPR: "Currently the product is available without a prescription only to those age 17 and over. As long ago as 2003, two FDA advisory panels recommended the product be made available over the counter without age restrictions" (Rovner, 12/7). 

The Hill: "Congressional Republicans had threatened a severe blowback if the FDA approved wider access to the drug" (Baker, 12/7).

This article was reprinted from kaiserhealthnews with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

©2017 -